Skip to main content

Orthotopic Heart Transplantation

  • Chapter
  • First Online:
  • 2997 Accesses

Abstract

Heart transplantation has become the most effective therapy for end-stage congestive heart failure. Since the first human-to-human transplant in 1967, outcomes have changed from relatively poor to a mean survival of more than 11 years, according to data reported in 2012. These improved outcomes and increased numbers of patients receiving orthotopic heart transplants are due to multiple reasons, including changes in immunosuppressive drugs, better management of heart failure patients on the waiting list, increasing use of ventricular assist devices (VADs) as bridge support, improved VAD technology, and improved donor organ preservation. Much of this chapter focuses on details of the orthotopic transplantation procedure itself. Other sections describe the steps involved in accepting transplant recipients and potential contraindications and how patients are prepared for the transplant. Criteria for donor acceptance are also described, as is the critical nature of the target time frame from donor heart availability to transplant, how a donor heart is checked for viability, considerations of posttransplant care including management of immunosuppressive agents, and monitoring for various types of potential rejection and how to treat them.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lower RR, Shumway NE. Studies on orthotopic homotransplantation of the +canine heart. Surg Forum. 1960;11:18–9.

    CAS  PubMed  Google Scholar 

  2. Barnard CN. What we have learned about heart transplants. J Thorac Cardiovasc Surg. 1968;56(4):457–68.

    CAS  PubMed  Google Scholar 

  3. Bolman 3rd RM, Elick B, Olivari MT, Ring WS, Arentzen CE. Improved immunosuppression for heart transplantation. J Heart Transplant. 1985;4(3):315–8.

    PubMed  Google Scholar 

  4. Baran DA, Galin ID, Gass AL. Current practices: immunosuppression induction, maintenance, and rejection regimens in contemporary post-heart transplant patient treatment. Curr Opin Cardiol. 2002;17(2):165–70.

    Article  CAS  PubMed  Google Scholar 

  5. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Hertz MI, International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report–2012. J Heart Lung Transplant. 2012;31(10):1052–64.

    Article  PubMed  Google Scholar 

  6. Young JB, Naftel DC, Bourge RC, Kirklin JK, Clemson BS, Porter CB, Rodeheffer RJ, Kenzora JL. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13(3):353–64.

    CAS  PubMed  Google Scholar 

  7. Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, PROCEED II trial investigators. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;27:2577–84.

    Article  Google Scholar 

  8. Bolman 3rd RM. Cardiac transplantation: the operative technique. Cardiovasc Clin. 1990;20(2):133–45.

    PubMed  Google Scholar 

  9. Liao KK, Bolman 3rd RM. Operative techniques in orthotopic heart transplantation. Semin Thorac Cardiovasc Surg. 2004;16(4):370–7.

    Article  PubMed  Google Scholar 

  10. John R, Liao K. Orthotopic heart transplantation. Oper Tech Thorac Cardiovasc Surg. 2010;15(2):138–46.

    Article  Google Scholar 

  11. Sievers HH, Weyand M, Kraatz EG, Bernhard A. An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium. Thorac Cardiovasc Surg. 1991;39(2):70–2.

    Article  CAS  PubMed  Google Scholar 

  12. Sarsam MA, Campbell CS, Yonan NA, Deiraniya AK, Rahman AN. An alternative surgical technique in orthotopic cardiac transplantation. J Card Surg. 1993;8(3):344–9.

    Article  CAS  PubMed  Google Scholar 

  13. Grande AM, Rinaldi M, D’Armini CC, Traversi E, Pederzolli C, Abbiate N, Klersy C, Viganò M. Orthotopic heart transplantation: standard versus bicaval technique. Am J Cardiol. 2000;85(11):1329–33.

    Article  CAS  PubMed  Google Scholar 

  14. Leyh RG, Jahnke AW, Kraatz EG, Sievers HH. Cardiovascular dynamics and dimensions after bicaval and standard cardiac transplantation. Ann Thorac Surg. 1995;59(6):1495–500.

    Article  CAS  PubMed  Google Scholar 

  15. el-Gamel A, Deiraniya AK, Rahman AN, Campbell CS, Yonan NA. Orthotopic heart transplantation hemodynamics: does atrial preservation improve cardiac output after transplantation? J Heart Lung Transplant. 1996;15(6):564–71.

    CAS  PubMed  Google Scholar 

  16. Beniaminovitz A, Savoia MT, Oz M, Galantowicz M, Di Tullio MR, Homma S, Mancini D. Improved atrial function in bicaval versus standard orthotopic techniques in cardiac transplantation. Am J Cardiol. 1997;80(12):1631–5.

    Article  CAS  PubMed  Google Scholar 

  17. Liao K, Shumway S. Cardiac transplantation. In: Yuh D, Vricella LA, Yang S, Doty JR, editors. Johns Hopkins textbook of cardiothoracic surgery. 2nd ed. New York: McGraw-Hill Medical; 2014. p. 783–95.

    Google Scholar 

  18. Stinson EB, Caves PK, Griepp RB, Oyer PE, Rider AK, Shumway NE. Hemodynamic observations in the early period after human heart transplantation. J Thorac Cardiovasc Surg. 1975;69(2):264–70.

    CAS  PubMed  Google Scholar 

  19. Cooper MM, Smith CR, Rose EA, Schneller SJ, Spotnitz HM. Permanent pacing following cardiac transplantation. J Thorac Cardiovasc Surg. 1992;104(3):812–6.

    CAS  PubMed  Google Scholar 

  20. Liao K, Shumway S, Colvin-Adams M, Missov E, Ranjit J. Abstract 296: intermediate clinical performance of the levitronix centrimag ventricular assist device in supporting cardiogenic shock patients. Circulation. 2010;122:A296.

    Google Scholar 

  21. Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72(4):638–41.

    Article  CAS  PubMed  Google Scholar 

  22. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet. 1999;353(9158):1083–91.

    Article  CAS  PubMed  Google Scholar 

  23. Halloran PF, Gourishankar S. Principles and overview of immunosuppression. In: Norman DJ, Turka LA, editors. Primer on transplantation. Mt Laurel, NJ: American Society of Transplantation; 2001. p. 87–98.

    Google Scholar 

  24. Kobashigawa J, Miller L, Russell S, et al. Randomized, prospective, multi-center comparison of tacrolimus, mycophenolate mofetil (MMF) and steroids vs tacrolimus, sirolimus and steroids vs cyclosporine, MMF and steroids in de novo cardiac transplant recipients 6-month report. J Heart Lung Transplant. 2004;23(suppl):S106.

    Article  Google Scholar 

  25. Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med. 2000;342(9):613–9.

    Article  CAS  PubMed  Google Scholar 

  26. Tan CD, Baldwin 3rd WM, Rodriguez ER. Update on cardiac transplantation pathology. Arch Pathol Lab Med. 2007;131(8):1169–91.

    PubMed  Google Scholar 

  27. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9(6):587–93.

    CAS  PubMed  Google Scholar 

  28. Michaels PJ, Espejo ML, Kobashigawa J, Alejos JC, Burch C, Takemoto S, Reed EF, Fishbein MC. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant. 2003;22(1):58–69.

    Article  PubMed  Google Scholar 

  29. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay Jr WA, Jones KW, O’Connell JB. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant. 1989;8(6):430–43.

    CAS  PubMed  Google Scholar 

  30. Park MH, Starling RC, Ratliff NB, McCarthy PM, Smedira NS, Pelegrin D, Young JB. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection. J Heart Lung Transplant. 1999;18(12):1224–7.

    Article  CAS  PubMed  Google Scholar 

  31. Krasinskas AM, Kreisel D, Acker MA, Bavaria JE, Pochettino A, Kotloff RM, Arcasoy S, Blumenthal N, Kamoun M, Moore JS, Rosengard BR. CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation. Transplantation. 2002;73(8):1339–41.

    Article  CAS  PubMed  Google Scholar 

  32. Adamson R, Obispo E, Dychter S, Dembitsky W, Moreno-Cabral R, Jaski B, Gordon J, Hoagland P, Moore K, King J, Andrews J, Rich M, Daily PO. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Transplant Proc. 1998;30(4):1107–9.

    Article  CAS  PubMed  Google Scholar 

  33. Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Kucheryavaya AY, Rahmel AO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth official adult heart transplant report–2009. J Heart Lung Transplant. 2009;28(10):1007–22.

    Article  PubMed  Google Scholar 

  34. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult heart transplant report–2010. J Heart Lung Transplant. 2010;29(10):1089–103.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenneth K. Liao MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Liao, K.K., John, R., Shumway, S.J. (2017). Orthotopic Heart Transplantation. In: Garry, D., Wilson, R., Vlodaver, Z. (eds) Congestive Heart Failure and Cardiac Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-44577-9_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44577-9_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44575-5

  • Online ISBN: 978-3-319-44577-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics